Terms: = Germ cell tumor AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Prognosis
423 results:
1. NPS-2143 inhibit glioma progression by suppressing autophagy through mediating AKT-mTOR pathway.
Nie JL; Li Q; Yin HT; Yang JH; Li M; Li Q; Fan XH; Zhao QQ; Wen ZP
J Cell Mol Med; 2024 Apr; 28(7):e18221. PubMed ID: 38509759
[TBL] [Abstract] [Full Text] [Related]
2. Assessment of Social Vulnerabilities of Care and prognosis in Adult Ocular Melanomas in the US.
Mensah JA; Fei-Zhang DJ; Rossen JL; Rahmani B; Bentrem DJ; Stein JD; French DD
Ann Surg Oncol; 2024 May; 31(5):3302-3313. PubMed ID: 38418655
[TBL] [Abstract] [Full Text] [Related]
3. tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro.
Cao Q; Hajosch A; Kast RE; Loehmann C; Hlavac M; Fischer-Posovszky P; Strobel H; Westhoff MA; Siegelin MD; Wirtz CR; Halatsch ME; Karpel-Massler G
Br J Cancer; 2024 May; 130(8):1365-1376. PubMed ID: 38396172
[TBL] [Abstract] [Full Text] [Related]
4. Pan-cancer analyses of bromodomain containing 9 as a novel therapeutic target reveals its diagnostic, prognostic potential and biological mechanism in human tumours.
Chen Y; Gao Z; Mohd-Ibrahim I; Yang H; Wu L; Fu Y; Deng Y
Clin Transl Med; 2024 Feb; 14(2):e1543. PubMed ID: 38303608
[TBL] [Abstract] [Full Text] [Related]
5. [Analysis of the influencing factors of short-term and long-term facial nerve function after vestibular schwannoma resection via suboccipital retrosigmoid approach].
Ren JW; Xu J; Huang X; Xu M; Chen MY; Wang Y; Wang W; Zhong P
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Dec; 58(12):1183-1190. PubMed ID: 38186092
[No Abstract] [Full Text] [Related]
6. SOMATIC DEFICIENT MISMATCH REPAIR ASSESSED BY IMMUNOHISTOCHEMISTRY AND CLINICAL FEATURES IN BRAZILIAN GLIOBLASTOMA PATIENTS.
Yamada CAF; Malheiros SMF; Do Amaral LLF; Lancellotti CLP
Exp Oncol; 2023 Dec; 45(3):297-311. PubMed ID: 38186025
[TBL] [Abstract] [Full Text] [Related]
7. Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
Augustin RC; Newman S; Li A; Joy M; Lyons M; Pham MP; Lucas P; Smith K; Sander C; Isett B; Davar D; Najjar YG; Zarour HM; Kirkwood JM; Luke JJ; Bao R
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857525
[TBL] [Abstract] [Full Text] [Related]
8. Status epilepticus in patients with glioblastoma: Clinical characteristics, risk factors, and epileptological outcome.
Stritzelberger J; Gesmann A; Fuhrmann I; Balk S; Reindl C; Madžar D; Uhl M; Welte TM; Brandner S; Eisenhut F; Dörfler A; Coras R; Adler W; Schwab S; Putz F; Fietkau R; Distel L; Hamer HM
Seizure; 2023 Nov; 112():48-53. PubMed ID: 37748366
[TBL] [Abstract] [Full Text] [Related]
9. Survival and neurological outcomes after stereotactic biopsy of diffuse intrinsic pontine glioma: a systematic review.
Dalmage M; LoPresti MA; Sarkar P; Ranganathan S; Abdelmageed S; Pagadala M; Shlobin NA; Lam S; DeCuypere M
J Neurosurg Pediatr; 2023 Dec; 32(6):665-672. PubMed ID: 37724839
[TBL] [Abstract] [Full Text] [Related]
10. Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trial.
Umemura Y; Orringer D; Junck L; Varela ML; West MEJ; Faisal SM; Comba A; Heth J; Sagher O; Leung D; Mammoser A; Hervey-Jumper S; Zamler D; Yadav VN; Dunn P; Al-Holou W; Hollon T; Kim MM; Wahl DR; Camelo-Piragua S; Lieberman AP; Venneti S; McKeever P; Lawrence T; Kurokawa R; Sagher K; Altshuler D; Zhao L; Muraszko K; Castro MG; Lowenstein PR
Lancet Oncol; 2023 Sep; 24(9):1042-1052. PubMed ID: 37657463
[TBL] [Abstract] [Full Text] [Related]
11. Epigenetic Regulation of the Expression of T cell Stimulatory and Inhibitory Factors by Histone H3 Lysine Modification Enzymes and Its Prognostic Roles in Glioblastoma.
Lee SH; Kim SH; Nam TM; Jang JH; Kim KH; Lee YS; Kim MS; Kim MS; Jin SY; Lee M; Lee SH; Kim YZ
J Korean Med Sci; 2023 Aug; 38(33):e258. PubMed ID: 37605497
[TBL] [Abstract] [Full Text] [Related]
12. Dissection of transcriptomic and epigenetic heterogeneity of grade 4 gliomas: implications for prognosis.
Zeng C; Song X; Zhang Z; Cai Q; Cai J; Horbinski C; Hu B; Cheng SY; Zhang W
Acta Neuropathol Commun; 2023 Aug; 11(1):133. PubMed ID: 37580817
[TBL] [Abstract] [Full Text] [Related]
13. Management and Long-term Outcomes of Adults With Medulloblastoma: A Single-Center Experience.
Neth BJ; Raghunathan A; Kizilbash SH; Uhm JH; Breen WG; Johnson DR; Daniels DJ; Sener U; Carabenciov ID; Campian JL; Khatua S; Mahajan A; Ruff MW
Neurology; 2023 Sep; 101(12):e1256-e1271. PubMed ID: 37524533
[TBL] [Abstract] [Full Text] [Related]
14. Histopathologic abundance of pigmentation correlates with disease-specific survival in malignant melanoma but is not independent of current AJCC pT stage.
Aebischer V; Abu-Ghazaleh A; Metzler G; Riedl L; Garbe C; Flatz L; Eigentler T; Forchhammer S
Pigment Cell Melanoma Res; 2023 Nov; 36(6):512-521. PubMed ID: 37469279
[TBL] [Abstract] [Full Text] [Related]
15. Risk of Mortality After a Diagnosis of Melanoma In Situ.
Patel VR; Roberson ML; Pignone MP; Adamson AS
JAMA Dermatol; 2023 Jul; 159(7):703-710. PubMed ID: 37285145
[TBL] [Abstract] [Full Text] [Related]
16. Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain tumor Funders' Collaborative Consortium (EORTC 1419).
Hertler C; Felsberg J; Gramatzki D; Le Rhun E; Clarke J; Soffietti R; Wick W; Chinot O; Ducray F; Roth P; McDonald K; Hau P; Hottinger AF; Reijneveld J; Schnell O; Marosi C; Glantz M; Darlix A; Lombardi G; Krex D; Glas M; Reardon DA; van den Bent M; Lefranc F; Herrlinger U; Razis E; Carpentier AF; Phillips S; Rudà R; Wick A; Tabouret E; Meyronet D; Maurage CA; Rushing E; Rapkins R; Bumes E; Hegi M; Weyerbrock A; Aregawi D; Gonzalez-Gomez C; Pellerino A; Klein M; Preusser M; Bendszus M; Golfinopoulos V; von Deimling A; Gorlia T; Wen PY; Reifenberger G; Weller M
Eur J Cancer; 2023 Aug; 189():112913. PubMed ID: 37277265
[TBL] [Abstract] [Full Text] [Related]
17. Routine imaging guided by a 31-gene expression profile assay results in earlier detection of melanoma with decreased metastatic tumor burden compared to patients without surveillance imaging studies.
Dhillon S; Duarte-Bateman D; Fowler G; Hagstrom MNE; Lampley N; Olivares S; Fumero-Velázquez MS; Vu K; Wayne JD; Gastman BR; Vetto J; Gerami P
Arch Dermatol Res; 2023 Oct; 315(8):2295-2302. PubMed ID: 36977840
[TBL] [Abstract] [Full Text] [Related]
18. Synthesis and the In Vitro Evaluation of Antitumor Activity of Novel Thiobenzanilides.
Álvaro-Martins MJ; Railean V; Martins F; Machuqueiro M; Pacheco R; Santos S
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838864
[TBL] [Abstract] [Full Text] [Related]
19. Assessment of Social Vulnerability in Pediatric Head and Neck Cancer Care and prognosis in the United States.
Fei-Zhang DJ; Chelius DC; Patel UA; Smith SS; Sheyn AM; Rastatter JC
JAMA Netw Open; 2023 Feb; 6(2):e230016. PubMed ID: 36800183
[TBL] [Abstract] [Full Text] [Related]
20. Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.
Dougherty J; Harvey K; Liou A; Labella K; Moran D; Brosius S; De Raedt T
PLoS One; 2023; 18(2):e0277305. PubMed ID: 36730269
[TBL] [Abstract] [Full Text] [Related]
[Next]
